{
  "id": 17944270,
  "title": "Truist reiterates Waystar stock rating on strong bookings growth",
  "url": "https://urgent.news/2026/11/03/truist-reiterates-waystar-stock-rating-on-strong-bookings-growth",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-03T09:50:57.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/truist-reiterates-waystar-stock-rating-on-strong-bookings-growth-93CH-4994095"
  },
  "original_language": "en",
  "account": "Truist Securities maintained a Buy rating and $33.00 price target on Waystar Holding (NASDAQ:WAY) after reviewing the company's impressive third-quarter results. Analysts across Wall Street express optimism, with a Strong Buy consensus among experts and price targets spanning from $28 to $44. At the current valuation of $28.14, the stock appears undervalued according to InvestingPro analysis. The company achieved a 10% organic revenue growth in Q3, with year-to-date bookings soaring 25% year-over-year. Large-client bookings surged more than 30%, while the implementation backlog expanded by over 50%. These strong performances have caught the attention of analysts, 7 of whom have revised their earnings estimates upwards for the upcoming period. Waystar's stock has gained a remarkable 34% over the past six months, providing a compelling return for investors. The company's updated guidance anticipates around 6% revenue growth in the fourth quarter, with management estimating a more robust 10% growth when accounting for factors like tough comparisons, the digital shift, and slower Iodine revenue conversion. Notably, Waystar's Iodine business postponed the Pre-Bill Anomaly Detection rollout by approximately six months to enhance the product. The company faced a significant loss of a major client from the academic medical center sector, but this client has since returned and is demonstrating robust demand for Pre-Bill, a product with a longer implementation timeline and outcome-based pricing model. Despite reporting a 43% adjusted EBITDA margin in Q3 and increasing its 2026 EBITDA guidance, Waystar experienced a 7.4% drop in the company's shares in after-hours trading due to concerns about near-term revenue growth expectations and a slower conversion of bookings into recognized sales. The company adjusted its full-year adjusted EBITDA guidance upward while lowering revenue growth expectations for the fourth quarter. The adoption of AI-powered offerings accounted for 43% of third-quarter bookings, reflecting strong demand for new products. However, analysts have yet to publicly update their ratings following the earnings report, leaving investors closely monitoring Waystar's financial trajectory.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}